Intranasal Ketamine for Procedural Sedation in Pediatric Laceration Repair
1 other identifier
interventional
45
1 country
1
Brief Summary
The purpose of this study is to compare how well three different doses of ketamine, given as a spray into the nose, help to sedate children and help them tolerate repairs of cuts on their faces.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started May 2007
Typical duration for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 21, 2007
CompletedFirst Posted
Study publicly available on registry
March 23, 2007
CompletedStudy Start
First participant enrolled
May 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2010
CompletedJuly 22, 2010
July 1, 2010
March 21, 2007
July 21, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Efficacy of sedation (OSBDR)
30 minutes
Time to onset of sedation (Ramsay 6-point Sedation Scale)
30 minutes
Secondary Outcomes (7)
Duration of sedation
Up to 1 hour
Primary caregiver satisfaction
24 hours
Physician satisfaction
Duration of procedure
Ketamine bioavailability
1 hour
Abnormalities in cardiopulmonary function
Until time of discharge
- +2 more secondary outcomes
Interventions
Eligibility Criteria
You may qualify if:
- Children between 1 to 7 years old
- Simple facial laceration, defined as: linear; requiring two or more sutures; no greater than 5.0 centimeters; does not cross the lid margin of the eye; does not require a plastics/face surgery consult; occured within the last 24 hours.
- Physician feels that intravenous sedation is required to perform the laceration repair
You may not qualify if:
- Closed head injury, any alteration in level of consciousness, clinical suspicion of intracranial injury or increased intracranial pressure
- Any conditions that qualify patient as American Society of Anesthesiologists' (ASA) III or IV
- Known diagnoses of hyperthyroidism or porphyria
- Glaucoma or penetrating eye injury
- Hypertension
- Any contraindication, including drug allergy, to study medications
- Severe trauma with other injuries requiring operative intervention
- Abnormal neurological exam in a previously normal child
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hasbro Children's Hospital
Providence, Rhode Island, 02903, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
James G Linakis, PhD, MD
Rhode Island Hospital
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
March 21, 2007
First Posted
March 23, 2007
Study Start
May 1, 2007
Study Completion
February 1, 2010
Last Updated
July 22, 2010
Record last verified: 2010-07